News
The Microcatheters Market is undergoing rapid expansion, fuelled by the growing adoption of minimally invasive procedures, ...
The global atherectomy devices market is expected to grow at a CAGR of ~8% during the forecast period. The increasing ...
The global health economics and outcomes research services market is expected to grow at a CAGR of ~13% during the forecast ...
DNA Methylation Market OverviewDNA methylation is a biological process in which methyl groups (CH3) are added to the DNA ...
The global neonatal intensive care respiratory devices market is expected to grow at a CAGR of ~6% during the forecast period ...
Kite Pharma will buy Interius BioTherapeutics for $350 million in cash to add an in vivo CAR‑T platform that creates T‑cell ...
Royalty Pharma will pay up to $950 million for a 7 percent royalty in Amgen’s Imdelltra, a breakthrough small cell lung ...
Spinal Implants Material Market OverviewThe global Spinal Implants Material Market is valued at USD 9.8 Million in 2024 and ...
CAL101 is a first-in-class monoclonal antibody targeting S100A4, a damage-associated molecular pattern (DAMP) protein associated with serious and life-threatening fibrotic disordersPhase 2 AURORA ...
Regulatory News:Celyad Oncology (Euronext: CYAD) (“Celyad” or the “Company”), today announced that it has decided to discontinue its research and development (R&D) activities and to implement a ...
Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, announces the completion of the first cohort in the clinical Phase I trial evaluating the drug candidate ...
The global ventricular assist devices (VAD) market is projected to grow at a CAGR of ~11% during the forecast period. This growth is primarily driven by the rising prevalence of heart failure, the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results